Sign up for a daily newsletter defining what matters in business and markets

Stories

Podcast: Cannabis capitalism

Medical marijuana company Tilray is now valued at more than $13 billion, after receiving DEA approval to import product to the US for clinical testing.

Dan talks with Tilray CEO Brendan Kennedy about the surprise decision and the broader cannabis market — which soon could include Coca-Cola — on today's Pro Rata podcast: